| 191.49 Delayed Data As of Mar 19 |  +0.18 / +0.09%Today’s Change | 163.31 Today|||52-Week Range 210.19 | -1.63% Year-to-Date |
| Regeneron, Sanofi Get EC Nod for Label Expansion of Praluent Mar 18 / Zacks.com - Paid Partner Content | Roche's (RHHBY) Tecentriq Gets FDA Approval for Breast Cancer Mar 12 / Zacks.com - Paid Partner Content |
| Better Buy: Amgen vs. Gilead Sciences Mar 17 / MotleyFool.com - Paid Partner Content | Is iShares Nasdaq Biotechnology Index Fund a Buy? Mar 11 / MotleyFool.com - Paid Partner Content |
| Roche Gets Approval for Label Expansion of MabThera in Europe Mar 15 / Zacks.com - Paid Partner Content | Is Amgen (AMGN) a Profitable Pick ForValue Investors Now? Mar 11 / Zacks.com - Paid Partner Content |
| Roche Receives EC Approval for Label Expansion of Hemlibra Mar 14 / Zacks.com - Paid Partner Content | Better Buy: Amgen vs. Biogen Mar 10 / MotleyFool.com - Paid Partner Content |
| Pfizer's Herceptin Biosimilar Trazimera Gets FDA Approval Mar 12 / Zacks.com - Paid Partner Content | Lilly's Emgality Gets FDA Priority Review for Cluster Headache Mar 06 / Zacks.com - Paid Partner Content |
| Previous close | 191.31 |
| Today’s open | 191.93 |
| Day’s range | 190.92 - 192.76 |
| Volume | 2,268,734 |
| Average volume (3 months) | 3,110,069 |
| Market cap | $118.9B |
| Earnings growth (last year) | -50.48% |
| Earnings growth (this year) | -2.01% |
| Earnings growth (next 5 years) | +5.50% |
| Revenue growth (last year) | +4.32% |
| P/E ratio | 15.2 |
| Price/Sales | 5.45 |
| Price/Book | 9.62 |
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | +0.47 | +0.72% |
| BIIBBiogen | -1.88 | -0.58% |
| ILMNIllumina Inc | +4.92 | +1.61% |
| EXASExact Sciences Corp | -0.78 | -0.85% |
| Next reporting date | April 23, 2019 |
| EPS forecast (this quarter) | $3.49 |
| Annual revenue (last year) | $23.8B |
| Annual profit (last year) | $8.4B |
| Net profit margin | 35.32% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Robert A. Bradway |
Executive Vice President- Operations Esteban Santos |
Corporate headquarters Thousand Oaks, California |
